Clinical Trial Update: Spirulina-Derived Product Alleviates Oral Mucositis in Patients Undergoing Radiotherapy for Malignant Head and Neck Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a spirulina-derived product for reducing radiation-induced oral mucositis in patients undergoing radiotherapy for head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Neoplasms

Drugs mentioned

• Spirulina-derived product

Snippet

Sponsor: West China Hospital | Conditions: Radiation-induced Oral Mucositis | Phase 2 | Status: ACTIVE_NOT_RECRUITING